{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:45:56Z","timestamp":1759776356219,"version":"3.37.3"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1P01CA120964"],"award-info":[{"award-number":["1P01CA120964"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167384","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T14:08:22Z","timestamp":1480601302000},"page":"e0167384","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex"],"prefix":"10.1371","volume":"11","author":[{"given":"Yanan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Dreier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juxiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Granter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"H Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/ddt597","article-title":"Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex","volume":"23","author":"ME Tyburczy","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref3","article-title":"Angiomyolipoma have common mutations in TSC2 but no other common genetic events","author":"W Qin","year":"2011","journal-title":"PLOS One"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"T Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/ajrccm.187.6.663","article-title":"Exonic mutations of TSC2\/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis","volume":"187","author":"KR Badri","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","first-page":"1639","article-title":"Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors","volume":"151","author":"EP Henske","year":"1997","journal-title":"Am J Path"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7","article-title":"Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas","volume":"15","author":"C Carbonara","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"e1006242","DOI":"10.1371\/journal.pgen.1006242","article-title":"Whole Exome Sequencing Identifies TSC1\/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development","volume":"12","author":"K Giannikou","year":"2016","journal-title":"PLoS Genet"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"DJ Kwiatkowski","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"7267","key":"ref10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature08486","article-title":"Pten in stromal fibroblasts suppresses mammary epithelial tumours","volume":"461","author":"AJ Trimboli","year":"2009","journal-title":"Nature"},{"issue":"21","key":"ref11","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"L Meikle","year":"2008","journal-title":"J Neurosci"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"LH Zeng","year":"2008","journal-title":"Ann Neurol"},{"issue":"9869","key":"ref13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"JJ Bissler","year":"2013","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis","volume":"364","author":"FX McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"H Zhang","year":"2003","journal-title":"J Clin Invest"},{"issue":"18","key":"ref16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"OJ Shah","year":"2004","journal-title":"Curr Biol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"LS Harrington","year":"2004","journal-title":"J Cell Biol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/pros.21445","article-title":"Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts","volume":"72","author":"S Yu","year":"2012","journal-title":"Prostate"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1165\/rcmb.2015-0111OC","article-title":"Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis","volume":"54","author":"Q Zhou","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0090-4295(93)90504-4","article-title":"Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis: forme fruste of tuberous sclerosis?","volume":"41","author":"LA Kerr","year":"1993","journal-title":"Urology"},{"issue":"5","key":"ref21","first-page":"321","article-title":"Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d&apos;Etudes et de Recherche sur les Maladies &quot;Orphelines&quot; Pulmonaires (GERM&quot;O&quot;P)","volume":"78","author":"T Urban","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1183\/09031936.96.09030399","article-title":"Lymphangioleiomyomatosis and tuberous sclerosis: where is the border?","volume":"9","author":"F Bonetti","year":"1996","journal-title":"Eur Respir J"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.2008.189","article-title":"Cathepsin-k expression in pulmonary lymphangioleiomyomatosis","volume":"22","author":"M Chilosi","year":"2009","journal-title":"Mod Pathol"},{"issue":"3\u20134","key":"ref24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2119\/2006-00070.Lim","article-title":"Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells?","volume":"13","author":"SD Lim","year":"2007","journal-title":"Mol Med"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","article-title":"Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis","volume":"21","author":"Y Matsumoto","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis","volume":"52","author":"X Zhe","year":"2004","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/lrb.2006.4.143","article-title":"Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis","volume":"4","author":"K Seyama","year":"2006","journal-title":"Lymphat Res Biol"},{"key":"ref28","first-page":"285","article-title":"Tuberous Sclerosis Complex","author":"T Darling","year":"2010"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/11634580-000000000-00000","article-title":"Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin","volume":"12","author":"MK Koenig","year":"2012","journal-title":"Drugs R D"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T01:20:53Z","timestamp":1568596853000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167384"}},"subtitle":[],"editor":[{"given":"David J.","family":"Reiner","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167384","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}